Form 4 for ENTX Entera Bio Ltd.
Accepted 2022-01-19 00:00:00 ET · period of report 2022-01-14 · accession 0001178913-22-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-19 | 2022-01-14 | ENTX | Toledano Miranda Jayne | Dir | P - Purchase | $2.79 | +6,800 | 6,800 | New | +$19.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2022-01-14 | P | A | 6,800 | $2.79 | 6,800 | D | — | — |